US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Dermata Therapeutics Inc

0.7590

-0.0069-0.90%

Volume:58.91K

Turnover:45.15K

Market Cap:4.12M

PE:-0.09

High:0.7900

Open:0.7900

Low:0.7450

Close:0.7659

Loading ...

Overview Company News Filings

Dermata’s XYNGARI trial hits statistically significant difference at 4 weeks

BRIEF-Dermata Therapeutics Inc - Announces Topline Results From Phase 3 Trial Of Xyngari - SEC Filing

Dermata Therapeutics Inc - Announces Topline Results From Phase 3 Trial of Xyngari - SEC Filing

THOMSON REUTERS

Buy Rating for Dermata Therapeutics: Promising Phase 3 Results and Strategic Advantages

Dermata Therapeutics Announces Exercise of Warrants for $6.2 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules

ACCESS Newswire

Gold Gains Over 1%; TD SYNNEX Shares Plunge After Downbeat Results

Dermata Therapeutics Shares Surge on Positive Acne Treatment Study

Dermata Therapeutics Shares up 68% as Acne Treatment Succeeds Late-Stage Study

THOMSON REUTERS

BUZZ-U.S. STOCKS ON THE MOVE-Lockheed Martin, New Fortress Energy, Northrop Grumman

BUZZ-Dermata Therapeutics rises after positive late-stage study data of acne treatment

BRIEF-Dermata's XYNGARI™ Phase 3 Trial Topline Data Meets All Primary Endpoints

Dermata Therapeutics Inc - to Initiate Second Phase 3 Trial for Xyngari in H2 2025

THOMSON REUTERS

Dermata Therapeutics Inc: Xyngari™ Achieved Its Primary Endpoints

THOMSON REUTERS

Dermata Therapeutics Inc - Announces Positive Phase 3 Results for Xyngari in Acne Treatment

THOMSON REUTERS

Breaking: Dermata's Xyngari™ Phase 3 Trial Topline Data Meets All Primary Endpoints

THOMSON REUTERS

Dermata Therapeutics Shares Halted for News Pending Premarket

THOMSON REUTERS

Dermata Therapeutics Provides Corporate Update and Reports Year End 2024 Financial Results

ACCESS Newswire

BRIEF-Dermata Announces That Last Patient Completes Last Visit In Pivotal Xyngari Phase 3 Star-1 Clinical Trial For Acne

Dermata Therapeutics announces last patient visit in Phase 3 acne trial

Dermata Therapeutics Inc - Topline Data Expected by End of March 2025

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/DRMA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DRMA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DRMA\",,,,,undefined,":{"symbol":"DRMA","market":"US","secType":"STK","nameCN":"Dermata Therapeutics Inc","latestPrice":0.759,"timestamp":1745946421417,"preClose":0.7659,"halted":0,"volume":58912,"delay":0,"floatShares":3995771,"shares":5430648,"eps":-8.032217,"marketStatus":"Trading","change":-0.0069,"latestTime":"04-29 13:11:24 EDT","open":0.79,"high":0.79,"low":0.745,"amount":45149.56768,"amplitude":0.058754,"askPrice":0.7639,"askSize":298,"bidPrice":0.745,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-8.032217,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1745956800000},"marketStatusCode":2,"adr":0,"listingDate":1628827200000,"exchange":"NASDAQ","adjPreClose":0.7659,"preHourTrading":{"tag":"盘前","latestPrice":0.796,"preClose":0.7659,"latestTime":"09:25 EDT","volume":2526,"amount":1883.0413061999998,"timestamp":1745933132757},"postHourTrading":{"tag":"盘后","latestPrice":0.7789,"preClose":0.752,"latestTime":"19:55 EDT","volume":4202,"amount":3288.206,"timestamp":1745884515247},"volumeRatio":0.397143},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DRMA\",,,,,undefined,":{"symbol":"DRMA","floatShares":3995771,"roa":"-135.87%","roe":"-310.44%","lyrEps":-8.032217,"volumeRatio":0.397143,"shares":5430648,"dividePrice":0,"high":0.79,"amplitude":0.058754,"preClose":0.7659,"low":0.745,"week52Low":0.69,"pbRate":"2.64","week52High":6.171,"institutionHeld":0,"latestPrice":0.759,"committee":0.540832,"eps":-8.032217,"divideRate":0,"volume":58912,"delay":0,"ttmEps":-8.032217,"open":0.79,"prevYearClose":1.35,"prevWeekClose":0.739,"prevMonthClose":1.08,"prevQuarterClose":1.08,"fiveDayClose":0.7136,"twentyDayClose":1.08,"sixtyDayClose":1.23},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DRMA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2527127864","title":"Dermata’s XYNGARI trial hits statistically significant difference at 4 weeks","url":"https://stock-news.laohu8.com/highlight/detail?id=2527127864","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527127864?lang=en_us&edition=fundamental","pubTime":"2025-04-15 21:36","pubTimestamp":1744724164,"startTime":"0","endTime":"0","summary":"Dermata Therapeutics (DRMA) announced that additional analysis of topline data from its Phase 3 STAR-1 trial showed that XYNGARI had a statisticall...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/dermatas-xyngari-trial-hits-statistically-significant-difference-at-4-weeks?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/dermatas-xyngari-trial-hits-statistically-significant-difference-at-4-weeks?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4539","DRMA","BK4139"],"gpt_icon":0},{"id":"2527112214","title":"BRIEF-Dermata Therapeutics Inc - Announces Topline Results From Phase 3 Trial Of Xyngari - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2527112214","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527112214?lang=en_us&edition=fundamental","pubTime":"2025-04-15 21:15","pubTimestamp":1744722917,"startTime":"0","endTime":"0","summary":"BRIEF-Dermata Therapeutics Inc - Announces Topline Results From Phase 3 Trial Of Xyngari - SEC FilingApril 15  - Dermata Therapeutics Inc DRMA.O:DERMATA THERAPEUTICS INC - ANNOUNCES TOPLINE RESULTS FROM PHASE 3 TRIAL OF XYNGARI - SEC FILINGSource text: [ID:n0001654954-25-004265]Further company coverage: DRMA.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nFWN3QT14B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","DRMA","BK4007"],"gpt_icon":0},{"id":"2527415623","title":"Dermata Therapeutics Inc - Announces Topline Results From Phase 3 Trial of Xyngari - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2527415623","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527415623?lang=en_us&edition=fundamental","pubTime":"2025-04-15 20:32","pubTimestamp":1744720371,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nFWN3QT14B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4007","BK4139","DRMA"],"gpt_icon":0},{"id":"2523332682","title":"Buy Rating for Dermata Therapeutics: Promising Phase 3 Results and Strategic Advantages","url":"https://stock-news.laohu8.com/highlight/detail?id=2523332682","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523332682?lang=en_us&edition=fundamental","pubTime":"2025-03-29 02:55","pubTimestamp":1743188112,"startTime":"0","endTime":"0","summary":"Maxim Group analyst Anthony Vendetti reiterated a Buy rating on Dermata Therapeutics (DRMA – Research Report) yesterday and set a price target of $...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-for-dermata-therapeutics-promising-phase-3-results-and-strategic-advantages?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-for-dermata-therapeutics-promising-phase-3-results-and-strategic-advantages?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DRMA","LENZ"],"gpt_icon":0},{"id":"2522557710","title":"Dermata Therapeutics Announces Exercise of Warrants for $6.2 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2522557710","media":"ACCESS Newswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522557710?lang=en_us&edition=fundamental","pubTime":"2025-03-28 08:15","pubTimestamp":1743120900,"startTime":"0","endTime":"0","summary":"SAN DIEGO, CA / ACCESS Newswire / March 27, 2025 / Dermata Therapeutics, Inc.  , a late-stage biotechnology company focused on the treatment of medical skin diseases and aesthetic applications, today announced the entry into a definitive agreement for the immediate exercise of certain outstanding warrants to purchase an aggregate of 4,834,470 shares of the Company's common stock, having exercise prices of $1.58 and $4.91 per share, issued by Dermata in September 2024  and May 2024 , at a reduced exercise price of $1.284 per share. The shares of common stock issuable upon exercise of the warrants are registered pursuant to effective registration statements on Form S-3 . The closing of the offering is expected to occur on or about March 28, 2025, subject to satisfaction of customary closing conditions.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/dermata-therapeutics-announces-exercise-warrants-001500364.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B64PRP62.GBP","IE00BGHQF748.EUR","TSYW.SI","QID","IE00B3QW5Z07.USD","NQmain","USJW.SI","LU2210150020.SGD","MNQmain","NVIW.SI","PSQ","DRMA","BK4539","BK4007","LU2210149790.SGD",".IXIC","IE00BKPKM429.USD","LENZ","SQQQ","BK4588","TQQQ","DRMAW","BK4139","USAW.SI","BK4585","LU2095319765.USD","QLD","BK4112","NDAQ"],"gpt_icon":1},{"id":"2522589511","title":"Gold Gains Over 1%; TD SYNNEX Shares Plunge After Downbeat Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2522589511","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522589511?lang=en_us&edition=fundamental","pubTime":"2025-03-28 00:12","pubTimestamp":1743091973,"startTime":"0","endTime":"0","summary":" ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/25/03/44519152/gold-gains-1-td-synnex-shares-plunge-after-downbeat-results","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["USJW.SI","BK4214","BK4585","BK4207","QID","TD","BK4568","NVIW.SI","PSQ","EQ","GTEC","SNX","BK4007","BK4149","QLD","DRMA","NQmain","BK4023","BK4561","AUUD",".IXIC","TSYW.SI","BK4140","MNQmain","NXU","TQQQ","USAW.SI","BK4139","BK4161","SQQQ","BK4539","SLNO","BK4566"],"gpt_icon":1},{"id":"2522301245","title":"Dermata Therapeutics Shares Surge on Positive Acne Treatment Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2522301245","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522301245?lang=en_us&edition=fundamental","pubTime":"2025-03-27 21:57","pubTimestamp":1743083820,"startTime":"0","endTime":"0","summary":"Dermata Therapeutics shares jumped more than 50% in early trading Thursday after the biotechnology company said its Xyngari once-weekly, topical product candidate for the treatment of moderate-to-severe acne hit its goals in a late-stage study.Shares of the San Diego company were recently changing hands at $2.05, up 52%.Dermata said Xyngari met all three primary endpoints in the Phase 3 study by achieving a statistically significant difference when compared with placebo after 12 weeks.Dermata said it plans to launch a second Phase 3 study in the second half of the year followed by an open-label extension study, adding that positive Phase 3 program will help support the filing of a new-drug application with the U.S. Food and Drug Administration.The company said it also plans to hold talks with potential partners interested in securing future rights to Xyngari.Dermata said it believes a once-weekly topical acne product like Xyngari could lead to improved patient compliance, as all curren","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BK4539","BK4139","DRMA","BK4007"],"gpt_icon":0},{"id":"2522309550","title":"Dermata Therapeutics Shares up 68% as Acne Treatment Succeeds Late-Stage Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2522309550","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522309550?lang=en_us&edition=fundamental","pubTime":"2025-03-27 21:33","pubTimestamp":1743082383,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nFWN3QA147:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","DRMA","BK4007"],"gpt_icon":0},{"id":"2522064633","title":"BUZZ-U.S. STOCKS ON THE MOVE-Lockheed Martin, New Fortress Energy, Northrop Grumman","url":"https://stock-news.laohu8.com/highlight/detail?id=2522064633","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522064633?lang=en_us&edition=fundamental","pubTime":"2025-03-27 21:25","pubTimestamp":1743081930,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Lockheed Martin, New Fortress Energy, Northrop GrummanEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning N","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nL6N3QA0GZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","LU1720051108.HKD","SNX","BWIN","IE00B5949003.HKD","BWA","BK4596","LU0320765059.SGD","BK4543","LU1815333072.USD","TSYW.SI","IE00BZ1G4Q59.USD","NEM","LMT","LU1551013342.USD","LU0072461881.USD","LU1935043023.USD","LU0787776722.HKD","LU1046421795.USD","NFE","F","AU","WOOF","LU0109391861.USD","DRMA","BK4592","NOC","BK4566","IAC","BK4605","GM","IE00BK4W5L77.USD","ANGI","BK4612","LU1221951129.SGD","REX","LU2168564065.EUR","APTV","PAYX","SLNO","LU0234570918.USD","LU0158827781.USD","GEV","LU0251132253.USD","CAVA","LU1670627923.USD"],"gpt_icon":1},{"id":"2522237017","title":"BUZZ-Dermata Therapeutics rises after positive late-stage study data of acne treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2522237017","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522237017?lang=en_us&edition=fundamental","pubTime":"2025-03-27 20:32","pubTimestamp":1743078756,"startTime":"0","endTime":"0","summary":"BUZZ-Dermata Therapeutics rises after positive late-stage study data of acne treatment** Drug developer Dermata Therapeutics' DRMA.O shares rise 8.2% to $1.46 premarket** Company says its experimental drug xyngari meet primary main goal to treat moderate-to-severe acne in a late-stage study** Main goals of the late-stage study were to measure the average change in both inflammatory and non-inflammatory skin blemishes and to assess the treatment response using a common scale called Investigator Global Assessment ** Company says xyngari showed \"highly statistically significant and clinically meaningful improvement\" in acne compared to placebo after 12 weeks of once-weekly treatment** Company says it is set to launch the drug in H2 2025**  As of last close, Dermata's shares down ~78% in past 12 months","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nL3N3QA10C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4139","BK4539","DRMA"],"gpt_icon":0},{"id":"2522708563","title":"BRIEF-Dermata's XYNGARI™ Phase 3 Trial Topline Data Meets All Primary Endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2522708563","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522708563?lang=en_us&edition=fundamental","pubTime":"2025-03-27 20:25","pubTimestamp":1743078329,"startTime":"0","endTime":"0","summary":"BRIEF-Dermata's XYNGARI Phase 3 Trial Topline Data Meets All Primary EndpointsMarch 27 (Reuters) - Dermata Therapeutics Inc DRMA.O:BREAKING: DERMATA'S XYNGARI PHASE 3 TRIAL TOPLINE DATA MEETS ALL PRIM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nTUA86C9ZN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DRMA","BK4007","BK4539"],"gpt_icon":1},{"id":"2522725053","title":"Dermata Therapeutics Inc - to Initiate Second Phase 3 Trial for Xyngari in H2 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2522725053","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522725053?lang=en_us&edition=fundamental","pubTime":"2025-03-27 20:00","pubTimestamp":1743076814,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nTUA86C9ZN:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DRMA","BK4007","BK4139","BK4539"],"gpt_icon":0},{"id":"2522437257","title":"Dermata Therapeutics Inc: Xyngari™ Achieved Its Primary Endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2522437257","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522437257?lang=en_us&edition=fundamental","pubTime":"2025-03-27 20:00","pubTimestamp":1743076814,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nTUA86C9ZN:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","DRMA","BK4539","BK4007"],"gpt_icon":0},{"id":"2522337268","title":"Dermata Therapeutics Inc - Announces Positive Phase 3 Results for Xyngari in Acne Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2522337268","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522337268?lang=en_us&edition=fundamental","pubTime":"2025-03-27 20:00","pubTimestamp":1743076814,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nTUA86C9ZN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","BK4007","DRMA"],"gpt_icon":0},{"id":"2522137250","title":"Breaking: Dermata's Xyngari™ Phase 3 Trial Topline Data Meets All Primary Endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2522137250","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522137250?lang=en_us&edition=fundamental","pubTime":"2025-03-27 20:00","pubTimestamp":1743076814,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nTUA86C9ZN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DRMA","BK4539","BK4007","BK4139"],"gpt_icon":0},{"id":"2522732374","title":"Dermata Therapeutics Shares Halted for News Pending Premarket","url":"https://stock-news.laohu8.com/highlight/detail?id=2522732374","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522732374?lang=en_us&edition=fundamental","pubTime":"2025-03-27 19:57","pubTimestamp":1743076636,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nL3N3QA0Z5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","DRMA","BK4007","BK4139"],"gpt_icon":0},{"id":"2520689766","title":"Dermata Therapeutics Provides Corporate Update and Reports Year End 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2520689766","media":"ACCESS Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520689766?lang=en_us&edition=fundamental","pubTime":"2025-03-18 04:16","pubTimestamp":1742242560,"startTime":"0","endTime":"0","summary":"- Dermata expects to announce topline results from its XYNGARI Phase 3 Spongilla Treatment of Acne Research  clinical trial by end of March 2025 -. - The Company recently entered into a Clinical Trial Collaboration Agreement with Revance Therapeutics  to study DMT410 for the treatment of axillary hyperhidrosis -- Raised $2.55 million in gross proceeds from a private placement financing in January 2025, including participation from Dermata's Chief Executive Officer, Chief Financial Officer, and certain members of the Company's board of directors -. SAN DIEGO, CA / ACCESS Newswire / March 17, 2025 / Dermata Therapeutics, Inc.  , a late-stage biotechnology company focused on the treatment of medical skin diseases and aesthetic applications, today highlighted recent corporate progress and reported financial results for the year ended December 31, 2024.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/dermata-therapeutics-provides-corporate-reports-201600200.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","LENZ","DRMA","BK4539","DRMAW","BK4139"],"gpt_icon":0},{"id":"2516267410","title":"BRIEF-Dermata Announces That Last Patient Completes Last Visit In Pivotal Xyngari Phase 3 Star-1 Clinical Trial For Acne","url":"https://stock-news.laohu8.com/highlight/detail?id=2516267410","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516267410?lang=en_us&edition=fundamental","pubTime":"2025-03-04 22:16","pubTimestamp":1741097782,"startTime":"0","endTime":"0","summary":"BRIEF-Dermata Announces That Last Patient Completes Last Visit In Pivotal Xyngari Phase 3 Star-1 Clinical Trial For AcneMarch 4 (Reuters) - Dermata Therapeutics Inc DRMA.O:DERMATA ANNOUNCES THAT LAST ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nTUA9SYMLZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","DRMA","BK4007","BK4139"],"gpt_icon":0},{"id":"2516679360","title":"Dermata Therapeutics announces last patient visit in Phase 3 acne trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2516679360","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516679360?lang=en_us&edition=fundamental","pubTime":"2025-03-04 21:11","pubTimestamp":1741093894,"startTime":"0","endTime":"0","summary":"Dermata Therapeutics (DRMA) announced that the last patient has completed their last visit in the company’s first pivotal Phase 3 Spongilla Treatme...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/dermata-therapeutics-announces-last-patient-visit-in-phase-3-acne-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/dermata-therapeutics-announces-last-patient-visit-in-phase-3-acne-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DRMA","BK4139","LENZ","BK4007","BK4539"],"gpt_icon":0},{"id":"2516763546","title":"Dermata Therapeutics Inc - Topline Data Expected by End of March 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2516763546","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516763546?lang=en_us&edition=fundamental","pubTime":"2025-03-04 21:03","pubTimestamp":1741093382,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nTUA9SYMLZ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4539","DRMA","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":40,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DRMA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-17","symbol":"DRMA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1742184000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-11-13","symbol":"DRMA","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"post","actualEps":-2.04},{"market":"US","date":"2024-08-07","symbol":"DRMA","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723003200000,"reportTimeType":"post","actualEps":-4.18},{"market":"US","date":"2024-05-16","symbol":"DRMA","defaultRemindTime":1715866200000,"type":"split","dateTimestamp":1715832000000,"forFactor":15,"toFactor":1,"ratio":15},{"market":"US","date":"2024-05-15","symbol":"DRMA","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715745600000,"reportTimeType":"post","actualEps":-0.47}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DRMA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DRMA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1668312000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/DRMA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"DRMA","date":"2025-04-25","current":-0.331475,"percent":0.622914,"low":-13.951895,"twenty":-1.20334,"median":-0.420249,"eighty":-0.230739,"high":-0.142342,"avg":-1.333071,"sd":2.460914,"marketCap":4072986},"quantilePoints":[{"date":"2021-08-13","current":-10.344345,"twenty":-13.951895,"median":-13.951895,"eighty":-11.787365,"marketCap":42621442},{"date":"2021-08-20","current":-9.318565,"twenty":-12.640293,"median":-10.326693,"eighty":-9.726884,"marketCap":38394956},{"date":"2021-08-27","current":-10.693103,"twenty":-10.685018,"median":-10.309041,"eighty":-9.581344,"marketCap":44058420},{"date":"2021-09-03","current":-10.864921,"twenty":-11.246962,"median":-10.521287,"eighty":-9.694542,"marketCap":44766354},{"date":"2021-09-10","current":-9.237709,"twenty":-10.889178,"median":-10.357014,"eighty":-9.581344,"marketCap":38061811},{"date":"2021-09-17","current":-8.429157,"twenty":-10.830557,"median":-10.005834,"eighty":-9.25388,"marketCap":34730362},{"date":"2021-09-24","current":-10.430324,"twenty":-10.830557,"median":-10.167545,"eighty":-9.3408,"marketCap":42975699},{"date":"2021-10-01","current":-8.27393,"twenty":-10.693103,"median":-9.904967,"eighty":-8.89239,"marketCap":38311670},{"date":"2021-10-08","current":-7.770299,"twenty":-10.693103,"median":-9.712734,"eighty":-8.441285,"marketCap":35979655},{"date":"2021-10-15","current":-8.032007,"twenty":-10.68906,"median":-9.540917,"eighty":-8.115646,"marketCap":37191470},{"date":"2021-10-22","current":-7.644392,"twenty":-10.624377,"median":-9.278137,"eighty":-8.024093,"marketCap":35396652},{"date":"2021-10-29","current":-8.399837,"twenty":-10.418196,"median":-9.047362,"eighty":-8.024093,"marketCap":38894674},{"date":"2021-11-05","current":-10.360399,"twenty":-10.624377,"median":-9.20549,"eighty":-8.040821,"marketCap":47972874},{"date":"2021-11-12","current":-9.10492,"twenty":-10.418196,"median":-9.209243,"eighty":-8.079672,"marketCap":42159494},{"date":"2021-11-19","current":-4.797783,"twenty":-10.367826,"median":-9.121108,"eighty":-7.899804,"marketCap":27567745},{"date":"2021-11-26","current":-3.913599,"twenty":-10.360399,"median":-9.065349,"eighty":-7.770299,"marketCap":22487284},{"date":"2021-12-03","current":-3.319312,"twenty":-10.344345,"median":-8.752578,"eighty":-7.644392,"marketCap":19072548},{"date":"2021-12-10","current":-3.348302,"twenty":-10.342412,"median":-8.516765,"eighty":-7.087964,"marketCap":19239121},{"date":"2021-12-17","current":-3.478755,"twenty":-10.309041,"median":-8.399837,"eighty":-4.536877,"marketCap":19988697},{"date":"2021-12-23","current":-3.0729,"twenty":-10.244357,"median":-8.27393,"eighty":-3.867216,"marketCap":17656682},{"date":"2021-12-31","current":-2.522097,"twenty":-10.161283,"median":-8.157015,"eighty":-3.545431,"marketCap":14491805},{"date":"2022-01-07","current":-2.275686,"twenty":-10.130167,"median":-8.094062,"eighty":-3.490351,"marketCap":13075939},{"date":"2022-01-14","current":-2.246696,"twenty":-10.110836,"median":-8.027061,"eighty":-3.348302,"marketCap":12909367},{"date":"2022-01-21","current":-2.377149,"twenty":-10.046262,"median":-7.905201,"eighty":-3.232343,"marketCap":13658943},{"date":"2022-01-28","current":-2.956942,"twenty":-9.945314,"median":-7.806273,"eighty":-2.951144,"marketCap":16990392},{"date":"2022-02-04","current":-3.217848,"twenty":-9.88059,"median":-7.725332,"eighty":-3.026517,"marketCap":18489545},{"date":"2022-02-11","current":-1.652409,"twenty":-9.85221,"median":-7.644392,"eighty":-2.838084,"marketCap":9494631},{"date":"2022-02-18","current":-1.782862,"twenty":-9.686456,"median":-7.357448,"eighty":-2.516299,"marketCap":10244207},{"date":"2022-02-25","current":-1.797357,"twenty":-9.581344,"median":-7.022737,"eighty":-2.484411,"marketCap":10327493},{"date":"2022-03-04","current":-1.579935,"twenty":-9.565173,"median":-4.797783,"eighty":-2.368453,"marketCap":9078200},{"date":"2022-03-11","current":-1.348018,"twenty":-9.496447,"median":-4.007815,"eighty":-2.252494,"marketCap":7745620},{"date":"2022-03-18","current":-1.449481,"twenty":-9.385271,"median":-3.681682,"eighty":-2.174222,"marketCap":8328624},{"date":"2022-03-25","current":-1.913315,"twenty":-9.286223,"median":-3.558477,"eighty":-2.069859,"marketCap":10993783},{"date":"2022-04-01","current":-1.349025,"twenty":-9.226323,"median":-3.52224,"eighty":-1.837942,"marketCap":10660638},{"date":"2022-04-08","current":-1.237309,"twenty":-9.194854,"median":-3.486003,"eighty":-1.78866,"marketCap":9777804},{"date":"2022-04-14","current":-1.206745,"twenty":-9.166075,"median":-3.413528,"eighty":-1.753901,"marketCap":9536274},{"date":"2022-04-22","current":-1.338486,"twenty":-9.130821,"median":-3.348302,"eighty":-1.710388,"marketCap":10577352},{"date":"2022-04-29","current":-1.202663,"twenty":-9.100603,"median":-3.290323,"eighty":-1.658207,"marketCap":9504016},{"date":"2022-05-06","current":-1.039194,"twenty":-9.076141,"median":-3.217848,"eighty":-1.520216,"marketCap":8212208},{"date":"2022-05-13","current":-0.96213,"twenty":-9.008619,"median":-3.174364,"eighty":-1.449481,"marketCap":7603212},{"date":"2022-05-20","current":-0.770426,"twenty":-8.833433,"median":-3.0729,"eighty":-1.38195,"marketCap":6459040},{"date":"2022-05-27","current":-0.864198,"twenty":-8.745907,"median":-2.913457,"eighty":-1.355935,"marketCap":7245197},{"date":"2022-06-03","current":-0.757769,"twenty":-8.719225,"median":-2.833736,"eighty":-1.349025,"marketCap":6352927},{"date":"2022-06-10","current":-0.649359,"twenty":-8.543732,"median":-2.696035,"eighty":-1.331103,"marketCap":5444048},{"date":"2022-06-17","current":-0.532144,"twenty":-8.489799,"median":-2.507603,"eighty":-1.243632,"marketCap":4461351},{"date":"2022-06-24","current":-0.528292,"twenty":-8.441285,"median":-2.485861,"eighty":-1.23031,"marketCap":4429056},{"date":"2022-07-01","current":-0.564612,"twenty":-8.405701,"median":-2.391644,"eighty":-1.205372,"marketCap":4733553},{"date":"2022-07-08","current":-0.878836,"twenty":-8.356669,"median":-2.362655,"eighty":-1.192609,"marketCap":7367919},{"date":"2022-07-15","current":-0.81445,"twenty":-8.295514,"median":-2.268439,"eighty":-1.046129,"marketCap":6828118},{"date":"2022-07-22","current":-0.77626,"twenty":-8.209177,"median":-2.188717,"eighty":-0.900663,"marketCap":6507944},{"date":"2022-07-29","current":-0.639674,"twenty":-8.166009,"median":-2.174222,"eighty":-0.869261,"marketCap":5362848},{"date":"2022-08-05","current":-0.682488,"twenty":-8.155217,"median":-2.101748,"eighty":-0.858501,"marketCap":5721786},{"date":"2022-08-12","current":-0.726402,"twenty":-8.13723,"median":-2.022026,"eighty":-0.824753,"marketCap":6089952},{"date":"2022-08-19","current":-0.75014,"twenty":-8.108451,"median":-1.855336,"eighty":-0.814451,"marketCap":7338243},{"date":"2022-08-26","current":-0.658128,"twenty":-8.08327,"median":-1.804604,"eighty":-0.773926,"marketCap":6438137},{"date":"2022-09-02","current":-0.627251,"twenty":-8.049634,"median":-1.782862,"eighty":-0.769003,"marketCap":6136081},{"date":"2022-09-09","current":-0.743531,"twenty":-8.02805,"median":-1.754017,"eighty":-0.759508,"marketCap":7273589},{"date":"2022-09-16","current":-0.641295,"twenty":-7.978946,"median":-1.739377,"eighty":-0.753192,"marketCap":6273471},{"date":"2022-09-23","current":-0.557648,"twenty":-7.906999,"median":-1.710388,"eighty":-0.739857,"marketCap":5455192},{"date":"2022-09-30","current":-0.537098,"twenty":-7.874623,"median":-1.688646,"eighty":-0.730443,"marketCap":5254158},{"date":"2022-10-07","current":-0.61713,"twenty":-7.827857,"median":-1.616172,"eighty":-0.724116,"marketCap":6037079},{"date":"2022-10-14","current":-0.733204,"twenty":-7.791883,"median":-1.53174,"eighty":-0.717793,"marketCap":7172567},{"date":"2022-10-21","current":-0.673308,"twenty":-7.763104,"median":-1.478471,"eighty":-0.707208,"marketCap":6586639},{"date":"2022-10-28","current":-0.71508,"twenty":-7.730728,"median":-1.445755,"eighty":-0.712892,"marketCap":6995273},{"date":"2022-11-04","current":-0.660916,"twenty":-7.691157,"median":-1.401721,"eighty":-0.70428,"marketCap":6465413},{"date":"2022-11-11","current":-0.738184,"twenty":-7.665976,"median":-1.364569,"eighty":-0.699559,"marketCap":7746623},{"date":"2022-11-18","current":-0.813028,"twenty":-7.622808,"median":-1.355555,"eighty":-0.702636,"marketCap":8532056},{"date":"2022-11-25","current":-0.72847,"twenty":-7.583236,"median":-1.349025,"eighty":-0.703461,"marketCap":7644686},{"date":"2022-12-02","current":-0.73876,"twenty":-7.475653,"median":-1.348521,"eighty":-0.70428,"marketCap":7752674},{"date":"2022-12-09","current":-0.21577,"twenty":-7.145943,"median":-1.331103,"eighty":-0.697287,"marketCap":2264323},{"date":"2022-12-16","current":-0.260746,"twenty":-7.061873,"median":-1.288424,"eighty":-0.682166,"marketCap":2736309},{"date":"2022-12-23","current":-0.209773,"twenty":-6.940116,"median":-1.237309,"eighty":-0.673955,"marketCap":2201391},{"date":"2022-12-30","current":-0.471672,"twenty":-6.870541,"median":-1.231854,"eighty":-0.668874,"marketCap":4949803},{"date":"2023-01-06","current":-0.346495,"twenty":-5.212335,"median":-1.222554,"eighty":-0.657739,"marketCap":3636174},{"date":"2023-01-13","current":-0.320076,"twenty":-4.589058,"median":-1.204356,"eighty":-0.644925,"marketCap":3358933},{"date":"2023-01-20","current":-0.339096,"twenty":-4.258576,"median":-1.202069,"eighty":-0.640027,"marketCap":3558535},{"date":"2023-01-27","current":-0.387473,"twenty":-3.99477,"median":-1.167634,"eighty":-0.627309,"marketCap":4066207},{"date":"2023-02-03","current":-0.355653,"twenty":-3.925195,"median":-1.044973,"eighty":-0.619857,"marketCap":3732285},{"date":"2023-02-10","current":-0.32853,"twenty":-3.774449,"median":-0.96213,"eighty":-0.615562,"marketCap":3447650},{"date":"2023-02-17","current":-0.339802,"twenty":-3.672986,"median":-0.894537,"eighty":-0.608144,"marketCap":3565940},{"date":"2023-02-24","current":-0.346158,"twenty":-3.626602,"median":-0.874158,"eighty":-0.598929,"marketCap":3326896},{"date":"2023-03-03","current":-0.352569,"twenty":-3.559926,"median":-0.868379,"eighty":-0.585445,"marketCap":3388506},{"date":"2023-03-10","current":-0.299106,"twenty":-3.539633,"median":-0.858453,"eighty":-0.568157,"marketCap":2874685},{"date":"2023-03-17","current":-0.14263,"twenty":-3.52224,"median":-0.847625,"eighty":-0.558893,"marketCap":1370804},{"date":"2023-03-24","current":-0.382678,"twenty":-3.516442,"median":-0.826007,"eighty":-0.541889,"marketCap":3677886},{"date":"2023-03-31","current":-0.320555,"twenty":-3.501947,"median":-0.818853,"eighty":-0.529833,"marketCap":3080827},{"date":"2023-04-06","current":-0.295706,"twenty":-3.490351,"median":-0.814451,"eighty":-0.428308,"marketCap":2842003},{"date":"2023-04-14","current":-0.288251,"twenty":-3.472957,"median":-0.808704,"eighty":-0.383637,"marketCap":2770356},{"date":"2023-04-21","current":-0.710688,"twenty":-3.435271,"median":-0.789964,"eighty":-0.383637,"marketCap":6830360},{"date":"2023-04-28","current":-0.429892,"twenty":-3.377291,"median":-0.784631,"eighty":-0.387473,"marketCap":4131651},{"date":"2023-05-03","current":-0.372738,"twenty":-3.377291,"median":-0.782256,"eighty":-0.384596,"marketCap":3582357},{"date":"2023-05-12","current":-0.47959,"twenty":-3.365695,"median":-0.771545,"eighty":-0.387473,"marketCap":4609299},{"date":"2023-05-19","current":-0.648111,"twenty":-3.348302,"median":-0.770426,"eighty":-0.389531,"marketCap":5875065},{"date":"2023-05-26","current":-0.492653,"twenty":-3.342504,"median":-0.766869,"eighty":-0.393115,"marketCap":4465853},{"date":"2023-06-02","current":-0.478448,"twenty":-3.319312,"median":-0.75964,"eighty":-0.395103,"marketCap":4337086},{"date":"2023-06-09","current":-0.671938,"twenty":-3.261333,"median":-0.75922,"eighty":-0.4038,"marketCap":6091054},{"date":"2023-06-16","current":-0.65083,"twenty":-3.261333,"median":-0.751172,"eighty":-0.417467,"marketCap":5899712},{"date":"2023-06-23","current":-0.701841,"twenty":-3.226545,"median":-0.749417,"eighty":-0.417467,"marketCap":6362122},{"date":"2023-06-30","current":-0.605096,"twenty":-3.217848,"median":-0.743634,"eighty":-0.423431,"marketCap":5485138},{"date":"2023-07-07","current":-0.566398,"twenty":-3.206252,"median":-0.742797,"eighty":-0.428401,"marketCap":5134344},{"date":"2023-07-14","current":-0.576952,"twenty":-3.177263,"median":-0.738126,"eighty":-0.429892,"marketCap":5230015},{"date":"2023-07-21","current":-0.534736,"twenty":-3.136677,"median":-0.736307,"eighty":-0.434862,"marketCap":4847331},{"date":"2023-07-28","current":-0.496038,"twenty":-3.090294,"median":-0.733359,"eighty":-0.454058,"marketCap":4496537},{"date":"2023-08-04","current":-0.43975,"twenty":-3.026517,"median":-0.728603,"eighty":-0.444104,"marketCap":3986292},{"date":"2023-08-11","current":-0.408088,"twenty":-2.951144,"median":-0.728144,"eighty":-0.428401,"marketCap":3699279},{"date":"2023-08-18","current":-0.484167,"twenty":-2.919255,"median":-0.725975,"eighty":-0.429892,"marketCap":3890621},{"date":"2023-08-25","current":-0.440513,"twenty":-2.872872,"median":-0.722826,"eighty":-0.433835,"marketCap":3539827},{"date":"2023-09-01","current":-0.492105,"twenty":-2.838084,"median":-0.720771,"eighty":-0.430966,"marketCap":3954402},{"date":"2023-09-08","current":-0.464324,"twenty":-2.7946,"median":-0.715506,"eighty":-0.432576,"marketCap":3731169},{"date":"2023-09-15","current":-0.445156,"twenty":-2.719227,"median":-0.713219,"eighty":-0.43337,"marketCap":3577139},{"date":"2023-09-22","current":-0.428607,"twenty":-2.661247,"median":-0.709968,"eighty":-0.43337,"marketCap":3444156},{"date":"2023-09-29","current":-0.428607,"twenty":-2.519198,"median":-0.704335,"eighty":-0.429892,"marketCap":3444156},{"date":"2023-10-06","current":-0.377611,"twenty":-2.507603,"median":-0.703256,"eighty":-0.427647,"marketCap":3034365},{"date":"2023-10-13","current":-0.317725,"twenty":-2.504704,"median":-0.699812,"eighty":-0.42067,"marketCap":2553140},{"date":"2023-10-20","current":-0.273832,"twenty":-2.490209,"median":-0.693604,"eighty":-0.411831,"marketCap":2200433},{"date":"2023-10-27","current":-0.252799,"twenty":-2.484411,"median":-0.68763,"eighty":-0.410199,"marketCap":2031414},{"date":"2023-11-02","current":-0.234464,"twenty":-2.461219,"median":-0.682602,"eighty":-0.402016,"marketCap":1884081},{"date":"2023-11-10","current":-0.310343,"twenty":-2.417735,"median":-0.681828,"eighty":-0.387473,"marketCap":2493824},{"date":"2023-11-17","current":-0.302706,"twenty":-2.385846,"median":-0.678974,"eighty":-0.380484,"marketCap":2218929},{"date":"2023-11-24","current":-0.283955,"twenty":-2.37425,"median":-0.676544,"eighty":-0.37763,"marketCap":2081482},{"date":"2023-12-01","current":-0.324284,"twenty":-2.353958,"median":-0.672107,"eighty":-0.371988,"marketCap":2377105},{"date":"2023-12-08","current":-0.324371,"twenty":-2.310473,"median":-0.668874,"eighty":-0.363106,"marketCap":2377743},{"date":"2023-12-15","current":-0.334576,"twenty":-2.272787,"median":-0.659522,"eighty":-0.356054,"marketCap":2452550},{"date":"2023-12-22","current":-0.294504,"twenty":-2.258292,"median":-0.656183,"eighty":-0.352466,"marketCap":2158810},{"date":"2023-12-29","current":-0.293973,"twenty":-2.252494,"median":-0.654348,"eighty":-0.351825,"marketCap":2154917},{"date":"2024-01-05","current":-0.294456,"twenty":-2.2351,"median":-0.653941,"eighty":-0.349028,"marketCap":2158456},{"date":"2024-01-12","current":-0.258198,"twenty":-2.188717,"median":-0.65083,"eighty":-0.34403,"marketCap":1892675},{"date":"2024-01-19","current":-0.18829,"twenty":-2.188717,"median":-0.648111,"eighty":-0.340037,"marketCap":1380223},{"date":"2024-01-26","current":-0.223051,"twenty":-2.174222,"median":-0.64252,"eighty":-0.336671,"marketCap":1635033},{"date":"2024-02-02","current":-0.221023,"twenty":-2.174222,"median":-0.639674,"eighty":-0.335006,"marketCap":1620169},{"date":"2024-02-09","current":-0.212333,"twenty":-2.145232,"median":-0.63236,"eighty":-0.333176,"marketCap":1556467},{"date":"2024-02-16","current":-0.224499,"twenty":-2.101748,"median":-0.629722,"eighty":-0.330658,"marketCap":1645650},{"date":"2024-02-23","current":-0.206085,"twenty":-2.090152,"median":-0.628686,"eighty":-0.328765,"marketCap":1510668},{"date":"2024-03-01","current":-0.221602,"twenty":-2.064061,"median":-0.626254,"eighty":-0.327339,"marketCap":1624416},{"date":"2024-03-08","current":-0.377205,"twenty":-2.000284,"median":-0.620022,"eighty":-0.328158,"marketCap":2765034},{"date":"2024-03-15","current":-0.364847,"twenty":-1.92781,"median":-0.618111,"eighty":-0.328484,"marketCap":2674443},{"date":"2024-03-22","current":-0.363484,"twenty":-1.866932,"median":-0.614394,"eighty":-0.328718,"marketCap":2664451},{"date":"2024-03-28","current":-0.335918,"twenty":-1.837942,"median":-0.612132,"eighty":-0.328765,"marketCap":2618376},{"date":"2024-04-05","current":-0.353692,"twenty":-1.81765,"median":-0.609282,"eighty":-0.328765,"marketCap":2756921},{"date":"2024-04-12","current":-0.341814,"twenty":-1.803155,"median":-0.606436,"eighty":-0.329118,"marketCap":2664336},{"date":"2024-04-19","current":-0.289004,"twenty":-1.797357,"median":-0.602415,"eighty":-0.328671,"marketCap":2252696},{"date":"2024-04-26","current":-0.290627,"twenty":-1.78866,"median":-0.597741,"eighty":-0.326311,"marketCap":2265351},{"date":"2024-05-03","current":-0.290627,"twenty":-1.782862,"median":-0.591413,"eighty":-0.324336,"marketCap":2265351},{"date":"2024-05-10","current":-0.276528,"twenty":-1.765555,"median":-0.588628,"eighty":-0.321828,"marketCap":2155447},{"date":"2024-05-17","current":-0.265755,"twenty":-1.75393,"median":-0.581702,"eighty":-0.320555,"marketCap":2309091},{"date":"2024-05-24","current":-0.177764,"twenty":-1.745175,"median":-0.576952,"eighty":-0.318671,"marketCap":1544559},{"date":"2024-05-31","current":-0.185006,"twenty":-1.739377,"median":-0.576829,"eighty":-0.316483,"marketCap":1607482},{"date":"2024-06-07","current":-0.179129,"twenty":-1.727781,"median":-0.572875,"eighty":-0.3137,"marketCap":1556416},{"date":"2024-06-14","current":-0.203485,"twenty":-1.710388,"median":-0.568157,"eighty":-0.310397,"marketCap":1768040},{"date":"2024-06-21","current":-0.154635,"twenty":-1.710388,"median":-0.56589,"eighty":-0.306522,"marketCap":1343598},{"date":"2024-06-28","current":-0.150753,"twenty":-1.70459,"median":-0.564998,"eighty":-0.304679,"marketCap":1309867},{"date":"2024-07-05","current":-0.144283,"twenty":-1.695893,"median":-0.56288,"eighty":-0.302797,"marketCap":1253650},{"date":"2024-07-12","current":-0.166929,"twenty":-1.692994,"median":-0.56076,"eighty":-0.298438,"marketCap":1450411},{"date":"2024-07-15","current":-0.181894,"twenty":-1.690095,"median":-0.560061,"eighty":-0.298305,"marketCap":1580439},{"date":"2024-08-02","current":-0.197849,"twenty":-1.687196,"median":-0.559362,"eighty":-0.297987,"marketCap":1719074},{"date":"2024-08-09","current":-0.185006,"twenty":-1.664005,"median":-0.557394,"eighty":-0.294771,"marketCap":1816118},{"date":"2024-08-16","current":-0.276158,"twenty":-1.630667,"median":-0.552326,"eighty":-0.294485,"marketCap":2710920},{"date":"2024-08-23","current":-0.246666,"twenty":-1.59443,"median":-0.548632,"eighty":-0.292148,"marketCap":2421405},{"date":"2024-08-30","current":-0.230579,"twenty":-1.562541,"median":-0.541772,"eighty":-0.290627,"marketCap":2263487},{"date":"2024-09-06","current":-0.191702,"twenty":-1.535581,"median":-0.537511,"eighty":-0.28922,"marketCap":1881852},{"date":"2024-09-13","current":-0.194383,"twenty":-1.510504,"median":-0.535865,"eighty":-0.286919,"marketCap":1908172},{"date":"2024-09-20","current":-0.2346,"twenty":-1.495864,"median":-0.534736,"eighty":-0.285715,"marketCap":2302966},{"date":"2024-09-27","current":-0.207789,"twenty":-1.466875,"median":-0.530218,"eighty":-0.284026,"marketCap":2039770},{"date":"2024-10-04","current":-0.191702,"twenty":-1.449481,"median":-0.52326,"eighty":-0.283281,"marketCap":1881852},{"date":"2024-10-11","current":-0.179637,"twenty":-1.4465,"median":-0.503707,"eighty":-0.279733,"marketCap":1763414},{"date":"2024-10-18","current":-0.24307,"twenty":-1.425905,"median":-0.500042,"eighty":-0.277221,"marketCap":2386114},{"date":"2024-10-25","current":-0.212302,"twenty":-1.401721,"median":-0.493576,"eighty":-0.275851,"marketCap":2084074},{"date":"2024-10-31","current":-0.207687,"twenty":-1.396778,"median":-0.492105,"eighty":-0.271403,"marketCap":2038768},{"date":"2024-11-08","current":-0.206148,"twenty":-1.375626,"median":-0.47959,"eighty":-0.261137,"marketCap":2023666},{"date":"2024-11-15","current":-0.159321,"twenty":-1.367889,"median":-0.47558,"eighty":-0.258573,"marketCap":1795626},{"date":"2024-11-22","current":-0.208232,"twenty":-1.358718,"median":-0.471672,"eighty":-0.254498,"marketCap":2346883},{"date":"2024-11-29","current":-0.204303,"twenty":-1.357456,"median":-0.464324,"eighty":-0.252002,"marketCap":2302598},{"date":"2024-12-06","current":-0.219097,"twenty":-1.355555,"median":-0.460356,"eighty":-0.243328,"marketCap":2469329},{"date":"2024-12-13","current":-0.197368,"twenty":-1.349025,"median":-0.45734,"eighty":-0.24248,"marketCap":2224437},{"date":"2024-12-20","current":-0.190125,"twenty":-1.349025,"median":-0.450435,"eighty":-0.239963,"marketCap":2142806},{"date":"2024-12-27","current":-0.245569,"twenty":-1.349025,"median":-0.447618,"eighty":-0.239695,"marketCap":2767689},{"date":"2025-01-03","current":-0.25169,"twenty":-1.349025,"median":-0.445971,"eighty":-0.239982,"marketCap":2836667},{"date":"2025-01-10","current":-0.22815,"twenty":-1.348622,"median":-0.444482,"eighty":-0.239975,"marketCap":2571367},{"date":"2025-01-17","current":-0.240825,"twenty":-1.344205,"median":-0.440513,"eighty":-0.239975,"marketCap":2714221},{"date":"2025-01-24","current":-0.215475,"twenty":-1.337009,"median":-0.440513,"eighty":-0.237592,"marketCap":2428513},{"date":"2025-01-31","current":-0.217286,"twenty":-1.328364,"median":-0.43456,"eighty":-0.2346,"marketCap":2448921},{"date":"2025-02-07","current":-0.220907,"twenty":-1.317407,"median":-0.430591,"eighty":-0.232765,"marketCap":2489736},{"date":"2025-02-14","current":-0.204611,"twenty":-1.305814,"median":-0.42925,"eighty":-0.230669,"marketCap":2306067},{"date":"2025-02-21","current":-0.219097,"twenty":-1.259441,"median":-0.428607,"eighty":-0.230182,"marketCap":2469329},{"date":"2025-02-28","current":-0.21026,"twenty":-1.243632,"median":-0.425678,"eighty":-0.229225,"marketCap":2369739},{"date":"2025-03-07","current":-0.426882,"twenty":-1.237309,"median":-0.422654,"eighty":-0.229943,"marketCap":4811177},{"date":"2025-03-14","current":-0.416299,"twenty":-1.233093,"median":-0.425678,"eighty":-0.229961,"marketCap":4691892},{"date":"2025-03-21","current":-0.521521,"twenty":-1.231854,"median":-0.422654,"eighty":-0.229961,"marketCap":6408164},{"date":"2025-03-28","current":-0.627593,"twenty":-1.224135,"median":-0.426882,"eighty":-0.230182,"marketCap":7711520},{"date":"2025-04-04","current":-0.412001,"twenty":-1.222554,"median":-0.427144,"eighty":-0.230579,"marketCap":5062450},{"date":"2025-04-11","current":-0.34827,"twenty":-1.206745,"median":-0.425678,"eighty":-0.230646,"marketCap":4279350},{"date":"2025-04-17","current":-0.313796,"twenty":-1.206188,"median":-0.424288,"eighty":-0.230646,"marketCap":3855760},{"date":"2025-04-25","current":-0.331475,"twenty":-1.20334,"median":-0.420249,"eighty":-0.230739,"marketCap":4072986}],"updateTime":1745909856325}}}